摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(4-cyanophenyl)-4-pyridinecarboxamide | 876522-38-2

中文名称
——
中文别名
——
英文名称
N-(4-cyanophenyl)-4-pyridinecarboxamide
英文别名
N-(4-cyanophenyl)pyridine-4-carboxamide
N-(4-cyanophenyl)-4-pyridinecarboxamide化学式
CAS
876522-38-2
化学式
C13H9N3O
mdl
MFCD04726949
分子量
223.234
InChiKey
SZKDPJCRPBWUSB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    335.0±22.0 °C(Predicted)
  • 密度:
    1.28±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    17
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    65.8
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    N-(4-cyanophenyl)-4-pyridinecarboxamide1,10-二溴癸烷N,N-二甲基甲酰胺 为溶剂, 以66%的产率得到1,1'-(1,10-decanediyl)bis[4-[[4-(cyano)phenylamino]carbonyl]pyridinium bromide]
    参考文献:
    名称:
    Pyridinium cationic-dimer antimalarials, unlike chloroquine, act selectively between the schizont stage and the ring stage of Plasmodium falciparum
    摘要:
    Malaria is a leading cause of death in developing countries, and the emergence of strains resistant to the main therapeutic agent, chloroquine, has become a serious problem. We have developed cationic-dimer type antimalarials, MAP-610 and PMAP-H10, which are structurally different from chloroquine. In this study, we introduced several substituents on the terminal phenyl rings of PMAP-H10. The electronic and hydrophobic properties of the substituents were correlated with the antimalarial activity and cytotoxicity of the compounds, respectively. Studies with synchronized cultures of malarial plasmodia showed that our cationic-dimers act selectively between the schizont stage and the ring stage of the parasitic cycle, unlike chloroquine, which has a stage-independent action. Thus, the mechanism of action of our antimalarials appears to be different from that of chloroquine, and our compounds may be effective against chloroquine-resistant strains. (C) 2008 Published by Elsevier Ltd.
    DOI:
    10.1016/j.bmc.2008.04.051
  • 作为产物:
    描述:
    对氯苯甲腈4-吡啶甲酰胺potassium phosphate 、 (PAd2-DalPhos)NiCl(o-tol) 作用下, 以 叔丁醇 为溶剂, 反应 18.0h, 以79%的产率得到N-(4-cyanophenyl)-4-pyridinecarboxamide
    参考文献:
    名称:
    镍催化的伯酰胺和内酰胺与活化的(杂)芳基亲电试剂的N-芳基化
    摘要:
    据报道,使用空气稳定的预催化剂(PAd-DalPhos)Ni(o -tolyl )Cl(C1)可以使酰胺与(杂)芳基(假)卤化物进行第一个镍催化的N-芳基化反应。一系列结构多样的伯酰胺和内酰胺已与活化的(杂)芳基氯,溴化物,三氟甲磺酸盐,甲苯磺酸盐,甲磺酸盐和氨基磺酸亲电子试剂成功交叉偶联。
    DOI:
    10.1002/chem.201605095
点击查看最新优质反应信息

文献信息

  • Nickel-Catalyzed N-Arylation of Amides with (Hetero)aryl Electrophiles by Using a DBU/NaTFA Dual-Base System
    作者:Mark Stradiotto、Travis Lundrigan、Joseph P. Tassone
    DOI:10.1055/a-1337-6459
    日期:2021.10
    The first nickel-catalyzed N-arylation of amides with (hetero)aryl (pseudo)halides employing an organic amine base is described. When using Ni(COD)2/CyPAd-DalPhos catalyst mixtures in combination with DBU/NaTFA as a dual-base system, a diversity of (hetero)aryl chloride, bromide, tosylate, and mesylate electrophiles were successfully cross-coupled with structurally varied primary amides, as well as
    描述了使用有机胺碱对酰胺与(杂)芳基(伪)卤化物进行第一次镍催化的 N-芳基化反应。当使用 Ni(COD)2/CyPAd-DalPhos 催化剂混合物与 DBU/NaTFA 作为双碱体系时,多种(杂)芳基氯、溴、甲苯磺酸和甲磺酸亲电子试剂成功地与结构变化的交叉偶联伯酰胺,以及一系列仲酰胺、内酰胺和恶唑烷酮亲核试剂。
  • Direct synthesis of primary arylamines via C–N cross-coupling of aryl bromides and triflates with amides
    作者:M. Romero、Y. Harrak、J. Basset、J.A. Orúe、M.D. Pujol
    DOI:10.1016/j.tet.2009.01.033
    日期:2009.3
    Aryl halides and triflates are coupled with primary amides to give the corresponding arylamines in the presence of a palladium catalyst, a suitable ligand, and a base. The catalyst system performs well for a large number of different substrates at 100-150 degrees C without solvent, and with low catalyst levels (0.12 mol% Pd). Nicotinamide might be useful as a nitrogen source in the Pd-catalyzed amination reaction. (C) 2009 Elsevier Ltd. All rights reserved.
  • Nickel-Catalyzed N-Arylation of Primary Amides and Lactams with Activated (Hetero)aryl Electrophiles
    作者:Christopher M. Lavoie、Preston M. MacQueen、Mark Stradiotto
    DOI:10.1002/chem.201605095
    日期:2016.12.23
    The first nickelcatalyzed N‐arylation of amides with (hetero)aryl (pseudo)halides is reported, enabled by use of the air‐stable pre‐catalyst (PAd‐DalPhos)Ni(o‐tolyl)Cl (C1). A range of structurally diverse primary amides and lactams were cross‐coupled successfully with activated (hetero)aryl chloride, bromide, triflate, tosylate, mesylate, and sulfamate electrophiles.
    据报道,使用空气稳定的预催化剂(PAd-DalPhos)Ni(o -tolyl )Cl(C1)可以使酰胺与(杂)芳基(假)卤化物进行第一个镍催化的N-芳基化反应。一系列结构多样的伯酰胺和内酰胺已与活化的(杂)芳基氯,溴化物,三氟甲磺酸盐,甲苯磺酸盐,甲磺酸盐和氨基磺酸亲电子试剂成功交叉偶联。
  • Pyridinium cationic-dimer antimalarials, unlike chloroquine, act selectively between the schizont stage and the ring stage of Plasmodium falciparum
    作者:Mai Yoshikawa、Kazunori Motoshima、Kanji Fujimoto、Akihiro Tai、Hiroki Kakuta、Kenji Sasaki
    DOI:10.1016/j.bmc.2008.04.051
    日期:2008.6
    Malaria is a leading cause of death in developing countries, and the emergence of strains resistant to the main therapeutic agent, chloroquine, has become a serious problem. We have developed cationic-dimer type antimalarials, MAP-610 and PMAP-H10, which are structurally different from chloroquine. In this study, we introduced several substituents on the terminal phenyl rings of PMAP-H10. The electronic and hydrophobic properties of the substituents were correlated with the antimalarial activity and cytotoxicity of the compounds, respectively. Studies with synchronized cultures of malarial plasmodia showed that our cationic-dimers act selectively between the schizont stage and the ring stage of the parasitic cycle, unlike chloroquine, which has a stage-independent action. Thus, the mechanism of action of our antimalarials appears to be different from that of chloroquine, and our compounds may be effective against chloroquine-resistant strains. (C) 2008 Published by Elsevier Ltd.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐